@viewrayon43
Active 8 months, 4 weeks ago
BACKGROUND Metastatic colorectal cancer (mCRC) represents a substantial health burden globally and an increasing challenge in Asian countries. Treatment options include chemotherapy plus a vascular endothelial growth factor (VEGF) inhibitor (such as bevacizumab, aflibercept or ramucirumab), or anti-epidermal growth factor receptor (EGFR) […] View
Sorry, there was no activity found. Please try a different filter.